About CTPharma
CTPharma was established in 2013 in Rocky Hill, United States, with Tom Schultz serving as co-founder. Operations are centered on the production of medical cannabis products within the pharmaceutical sector. Manufacturing processes are conducted to meet regulatory standards for therapeutic applications. The company is based in the United States, focusing on domestic distribution and compliance in the cannabis industry.
- Headquarter Rocky Hill, United States
- Founders Tom Schultz
-
Sectors
Consumer
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ctpharma Incorporated
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of CTPharma
Detailed funding history for CTPharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in CTPharma
CTPharma has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Verano and Tuatara Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm investing and cannabis-focused consumer and retail firms
|
Locked | Locked | Locked | |
|
Cannabis products for health and wellbeing are developed and provided.
|
Locked | Locked | Locked |
Investor details for CTPharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CTPharma
Investment portfolio details for CTPharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CTPharma
Detailed financials for CTPharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ctpharma Comparisons
Peer comparison for CTPharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CTPharma
Detailed competitors of CTPharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ctpharma
Complete news archive for CTPharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CTPharma
CTPharma was founded in 2013.
CTPharma is headquartered in Rocky Hill, United States. It is registered at Rocky Hill, Connecticut, United States.
CTPharma was established in 2013 in Rocky Hill, United States, with Tom Schultz serving as co-founder. Operations are centered on the production of medical cannabis products within the pharmaceutical sector. Manufacturing processes are conducted to meet regulatory standards for therapeutic applications. The company is based in the United States, focusing on domestic distribution and compliance in the cannabis industry.
CTPharma has 2 investors. Key investors include Verano, and Tuatara Capital.